Skip to main content

A New Diphosphonate: Dissociation Between Effects on Cells and Mineral in Rats and a Preliminary Trial in Paget’s Disease

  • Chapter

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 103))

Abstract

Diphosphonates are of pharmacological interest because they act on bone (1). In animals they decrease the performance of osteoclasts and of osteoblasts and can hinder the mineralization of osteoid (2,3,4). The first two properties have been used to reduce bone turnover in patients with Paget’s disease by treatment with Ethane-l-hydroxy-1,1-diphosphonate (EHDP) (5). But, whilst the desired decrement of activity of the disease was often achieved, the hindrance of mineralization has caused excesse of unmineralized osteoid in the diseased bones (6). This is probably why patients treated with EHDP have had an increased incidence of pathological fractures (7,8,9). Is undermineralization a necessary price to pay for reduction of bone formation and resorption in Paget’s disease by diphosphonates?

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Russell, R.G.G. and Fleisch, H.: Pyrophosphate and diphosphonates in skeletal metabolism. Clin.Orthop.Rel.Res. 108: 241, 1975.

    Article  CAS  Google Scholar 

  2. Miller, S.C. and Jee, W.S.S.: The comparative effects of dichloromethylene diphosphonate (C12MDP) and ethane-1-hydroxy-1,1diphosphonate (EHDP) on growth and modeling of the rat tibia. Calc.Tiss.Res. 23: 207, 1977.

    Article  CAS  Google Scholar 

  3. Russell, R.G.G., Kislig, A.M., Casey, P.A., Fleisch, H., Thornton, J., Schenk, R. and Williams, D.A.: Effect of diphosphonates and calcitonin on the chemistry and quantitative histology of rat bone. Calc.Tiss.Res. 11: 179, 1973.

    Article  CAS  Google Scholar 

  4. Schenk, R., Merz, W.A., Miihlbauer, R., Russell, R.G.G. and Fleisch, H.: Effect of ethane-l-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (C12MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calc.Tiss.Res. 11: 196, 1973.

    Article  CAS  Google Scholar 

  5. Smith, R., Russell, R.G.G., Bishop, M.C., Woods, C.G. and Bishop, M.: Paget’s disease of bone: Experience with a diphosphonate (disodium etidronate) in treatment. Quart.Med. 42: 235, 1973.

    CAS  Google Scholar 

  6. Russell, R.G.G., Smith, R., Preston, C., Walton, R.J. and Woods, C.G.: Diphosphonates in Paget’s disease. Lancet (i): 894, 1974.

    Google Scholar 

  7. Fromm, G., Schajowicz, F. and Mautalen, C.A.: Disodium ethane1-hydroxy-1,1-diphosphonate in Paget’s disease. Lancet (ii): 666, 1975.

    Article  Google Scholar 

  8. Reiker, M., Jong, A., Seiler, A., Schenk, R. and Fleisch, H.: Le traitement de la maladie de Paget par les diphosphonates. Schweiz.med.Wschr. 105: 1701, 1975.

    Google Scholar 

  9. Finerman, G.A.M., Gronick, H.G., Smith, R.K., and Mayfield, J. Diphosphonate treatment of Paget’s disease. Clin.Orthop. 120: 115, 1976.

    PubMed  Google Scholar 

  10. Wuthier, R.E.: A zonal analysis of inorganic and organic constituents of the epiphysis during enchondral calcification. Calc.Tiss.Res. 4: 20, 1969.

    Article  CAS  Google Scholar 

  11. Russell, R.G.G. and Smith, R.: Diphosphonates - Experimental and clinical aspects. J.Bone Joint Surg.(Br) 55B: 66, 1973.

    CAS  Google Scholar 

  12. Wöltgens, J.H.M., Bonting, S.L. and Bijvoet, O.L.M.: Inorganic pyrophosphatase in mineralizing hamster molars. III. Influence of diphosphonates. Calc.Tiss.Res. 13: 151, 1973.

    Article  Google Scholar 

  13. Bijvoet, O.L.M., Hosking, D.J., Lemkes, H.H.P.J., Reitsma, P.H. and Frijlink, W.: Development in the treatment of Paget’s disease. To be published in: Proceedings of the Vth Parathyroid conference 1977. Elsevier, Amsterdam.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1978 Plenum Press, New York

About this chapter

Cite this chapter

Lemkes, H.H.P.J., Reitsma, P.H., Frijlink, W., Verlinden-Ooms, H., Bijvoet, O.L.M. (1978). A New Diphosphonate: Dissociation Between Effects on Cells and Mineral in Rats and a Preliminary Trial in Paget’s Disease. In: Massry, S.G., Ritz, E., Rapado, A. (eds) Homeostasis of Phosphate and Other Minerals. Advances in Experimental Medicine and Biology, vol 103. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7758-0_47

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-7758-0_47

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-7760-3

  • Online ISBN: 978-1-4684-7758-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics